DNA依赖性蛋白激酶抑制剂AZD7648对小鼠SCCVII肿瘤及正常组织的放射增敏作用
该临床前研究评估DNA-PK抑制剂AZD7648在常氧和缺氧条件下对头颈鳞癌细胞系的放射增敏作用,并利用SCCVII肿瘤、小鼠小肠和口腔黏膜模型评估对正常组织的放射增敏风险。结果显示AZD7648是强效放射增敏剂,肿瘤SER10为2.5,但同时对小肠隐窝和口腔黏膜干细胞产生相似程度的放射增敏。
要点
- AZD7648在常氧和缺氧条件下均强效放射增敏头颈鳞癌细胞系。
- SCCVII肿瘤经AZD7648增敏后SER10为2.5。
- AZD7648同样放射增敏小肠和口腔黏膜干细胞,SER与肿瘤相似。
核心结论
- AZD7648是常氧和缺氧肿瘤细胞的强效放射增敏剂,但也显著放射增敏小肠和口腔黏膜干细胞。
研究设计与样本
- 临床前研究:体外克隆形成实验评估AZD7648对UT-SCC-54C和SCCVII细胞系在常氧和缺氧条件下的放射增敏。
- C3H小鼠SCCVII肿瘤经口服AZD7648(75 mg/kg)后照射,照后3.5天行离体克隆形成实验。
- 利用5-乙炔基-2'-脱氧尿苷检测同一小鼠回肠再生隐窝及回肠和口腔黏膜再增殖S期细胞作为正常组织替代终点。
主要发现
- AZD7648强效放射增敏两种细胞系,常氧和缺氧条件下10%存活率的增敏比(SER10)相似。
- AZD7648快速穿透多细胞层,提示血浆与肿瘤缺氧区之间快速平衡。
- AZD7648使SCCVII肿瘤放射增敏,SER10为2.5。
- AZD7648加重放射诱导的体重下降,并抑制回肠再生隐窝及回肠和舌上皮再增殖S期细胞,SER值与SCCVII肿瘤相似。
关键数值与推荐
- AZD7648口服剂量为75 mg/kg。
- SCCVII肿瘤SER10为2.5。
- 正常组织(回肠隐窝、回肠和舌上皮S期细胞)SER值与SCCVII肿瘤相似。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Inhibitors of DNA-dependent protein kinase (DNA-PK) are effective radiation sensitisers in preclinical tumours, but little is known about risks of normal tissue radiosensitisation. Here, we evaluate radiosensitisation of head and neck squamous cell carcinoma (HNSCC) cells by DNA-PK inhibitor AZD7648 under oxia and anoxia in vitro, and tumour (SCCVII), oral mucosa and small intestine in mice. MATERIALS AND METHODS: Radiosensitisation of human (UT-SCC-54C) and murine (SCCVII) HNSCC cells by AZD7648 under oxia and anoxia was evaluated by clonogenic assay. Radiosensitisation of SCCVII tumours in C3H mice by oral AZD7648 (75 mg/kg) was determined by ex vivo clonogenic assay 3.5 days post-irradiation, with evaluation of normal tissue surrogate endpoints using 5-ethynyl-2'-deoxyuridine to facilitate detection of regenerating crypts in the ileum and repopulating S-phase cells in the ileum and oral mucosa of the same animals. RESULTS: AZD7648 potently radiosensitised both cell lines, with similar sensitiser enhancement ratios for 10% survival (SER10) under oxia and anoxia. AZD7648 diffused rapidly through multicellular layers, suggesting rapid equilibration between plasma and hypoxic zones in tumours. SCCVII tumours were radiosensitised by AZD7648 (SER10 2.5). AZD7648 also enhanced radiation-induced body weight loss and suppressed regenerating intestinal crypts and repopulating S-phase cells in the ileum and tongue epithelium with SER values similar to SCCVII tumours. CONCLUSION: AZD7648 is a potent radiation sensitiser of both oxic and anoxic tumour cells, but also markedly radiosensitises stem cells in the small intestine and oral mucosa.
引用
- Hong CR, Buckley CD, Wong WW, et al. Radiosensitisation of SCCVII tumours and normal tissues in mice by the DNA-dependent protein kinase inhibitor AZD7648. Radiother Oncol. 2021. PMID: 34861268. doi:10.1016/j.radonc.2021.11.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。